Federal contract award
W81K0223P0128
BIOMERIEUX ANALYZER, REAGENTS, SUPPLIES AND SERVICES FOR MAMC.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY HCD WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $534.0K |
| Current contract value | $534.0K |
| Potential contract value / ceiling | $534.0K |
| Start date | Oct 1, 2023 |
| Current end date | Sep 30, 2024 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | May 2, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 2, 2026 | P00008 | $0 | NUCLEIC ACID EXTRACTION ANALYZER |
| Apr 9, 2026 | P00007 | $0 | DHA TRANSFER |
| Apr 17, 2025 | P00006 | $-96.8K | BIOMERIEUX ANALYZER, REAGENTS, SUPPLIES AND SERVICES FOR MAMC. |
| Nov 6, 2024 | P00005 | $295.5K | MODIFICATION TO ADD FY25 FUNDING FOR OY 4, 10/1/24 - 9/30/25 |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.